Bargain, Value Trap or Something in Between? (Ben Inker and Anna Chetoukhina)
gmo.com · 2024-12-19 · tier T1
Source: Letter · gmo.com dated 2024-12-19. Auto-generated factual summary. Not investment advice. Verify before acting.
GMO's asset allocation team contends that U.S. large value equities have reached historically extreme cheapness—trading at the 7th percentile versus their own history—and are positioned to outperform after a decade of underperformance driven by falling valuations rather than deteriorating fundamentals. The firm argues that value stocks' underlying businesses remain sound, with positive fundamental returns persisting across historical periods, making them attractive especially in long/short portfolios where stock-specific risk can be controlled. U.S. small caps present a more complicated picture. While also trading at unusually low valuations relative to history, the team finds that falling relative valuation is partly justified by deteriorating profitability, increasing leverage, and slowing growth stemming from fewer IPOs and an aging cohort of public firms. The average age of small cap firms has risen roughly 15 years since the early 2000s as venture capital pools have delayed company maturity at IPO, reducing the dynamism of the small cap universe. Where GMO owns small caps, the firm emphasizes higher-quality businesses to mitigate these headwinds. China presents the most cautious case. Though valuations appear mildly attractive and China is the cheapest major market globally, the team identifies a troubling shift in fundamentals: after delivering world-leading returns from 2005–2014 driven by 17.5% real growth, China's fundamental returns have collapsed to -4.5% over the past decade. The deterioration stems from slowing growth (now 4.6% real), persistent shareholder dilution at -2.6% annually, and a -6.3% annual drag from index rebalancing as higher-valuation companies enter indices and free-float changes favor expensive sectors. Structurally, China's investment rate remains near 40%—far above peers—despite slowing GDP growth to 5%, a recipe for continued return-on-capital erosion. Geopolitical risks around Taiwan and regulatory uncertainty add further caution.
Citations · 6
“it is quite cheap now, at the 7th percentile versus history and a valuation of 0.6”
p#16 · confidence 95%
“Their poor trailing returns have primarily been driven by falling relative valuations, not by deterioration in their underlying businesses.”
p#5 · confidence 95%
“China's fundamental returns from 2005-2014 were the best in the world by a large margin...the last decade has been a disaster”
p#28 · confidence 92%
“small caps have on average become about 15 years older, while large caps have become a little younger”
p#53 · confidence 94%
“China's gross capital formation averaged around 40% over that period...Since 2010, China's growth has slowed materially, down to around 5%...Gross investment rates, however, have not come down.”
p#43 · confidence 93%
“in the 1980s and 1990s they had about 80-85% of the return on capital of large caps, whereas over the last twenty or so years it has fallen to around 65%”
p#40 · confidence 95%
Follow this investor
Jeremy Grantham
GMO quarterly · market valuations and climate
More from Jeremy Grantham
Browse all →- Letter
Inker isn't dismissing private equity, but views today's PE portfolios as a leveraged, low-quality, software-concentrated bet whose factor risks allocators should deliberately offset in their public…
Sources & details
- Letter
Summarized by DailySharpe AI